ARCHIVES

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: ASCO Letter To Clinton Urges support For Trials; Senator Praises NCI, Bristol; Berlin Back A NCI

January 15, 1993

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008

Calif., Illinois Enact ACCC Model Law On Reimbursement

October 23, 1992

Community Cancer Center Defined

September 27, 1974

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

April 2, 1976

NCI Asks $955 Million In ’78; HEW Says $799 Will Be Enough

August 20, 1976